Objective-To determine the role of prostacyclin (PGI 2 ) in protecting endothelial cells (ECs) from apoptosis and elucidate the protective mechanism. Methods and Results-To evaluate the effect of PGI 2 on EC survival, we treated ECs with Ad-COX1/PGIS (Ad-COPI), which augmented selectively PGI 2 production or carbaprostacyclin (cPGI 2 ) followed by H 2 O 2 for 4 hours. Ad-COPI inhibited annexin V-positive cells and blocked caspase 3 activation. cPGI 2 inhibited apoptosis in a concentrationdependent manner. L-165041 had a similar effect, suggesting the involvement of peroxisome proliferator-activated receptor-␦ (PPAR␦). ECs expressed functional PPAR␦. PPAR␦ overexpression enhanced whereas PPAR␦ knockdown by small interfering RNA abrogated the antiapoptotic action of cPGI 2 and L-165041. Our results show for the first time that PGI 2 stimulated 14-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.